Insider Trading Summary for Akebia Therapeutics, Inc. (AKBA): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
10-Jun-24 4:20 PM View:	06-Jun-24 Grant 0	Smith Cynthia Director		Akebia Therapeutics, Inc. - AKBA	32% 95.23K to 125.23K	0	0	--	--	Show Txns Hide Txns

10-Jun-24 4:18 PM View:	06-Jun-24 Grant 0	Adams Adrian Director		Akebia Therapeutics, Inc. - AKBA	22% 134.8K to 164.8K	0	0	--	--	Show Txns Hide Txns

10-Jun-24 4:19 PM View:	06-Jun-24 Grant 0	Gilman Steven C Director		Akebia Therapeutics, Inc. - AKBA	34% 87.13K to 117.13K	0	0	--	--	Show Txns Hide Txns

10-Jun-24 4:19 PM View:	06-Jun-24 Grant 0	Rogers Michael W Director		Akebia Therapeutics, Inc. - AKBA	31% 96.03K to 126.03K	0	0	--	--	Show Txns Hide Txns

01-Mar-24 5:47 PM View:	29-Feb-24 Sale ($73.58K)	Butler John P. CEO and President Director		Akebia Therapeutics, Inc. - AKBA	25% 1.89M to 2.36M	0	0	--	--	Show Txns Hide Txns

01-Mar-24 5:46 PM View:	29-Feb-24 Sale ($11.33K)	Burke Steven Keith SVP, Chief Medical Officer		Akebia Therapeutics, Inc. - AKBA	30% 533.49K to 695.84K	0	0	--	--	Show Txns Hide Txns

14-May-24 4:05 PM View:	13-May-24 Sale (Planned) ($15.14K)	Hadas Nicole R. SVP, Chief Legal Officer		Akebia Therapeutics, Inc. - AKBA	23% 527.34K to 651.24K	0	0	--	--	Show Txns Hide Txns

14-May-24 4:04 PM View:	13-May-24 Sale (Planned) ($43.90K)	Dahan Michel SVP, Chief Operating Officer		Akebia Therapeutics, Inc. - AKBA	16% 577.04K to 672.09K	0	0	--	--	Show Txns Hide Txns

10-Jun-24 4:20 PM View:	06-Jun-24 Grant 0	Wolf Myles Director		Akebia Therapeutics, Inc. - AKBA	44% 67.68K to 97.68K	0	0	--	--	Show Txns Hide Txns

10-Jun-24 4:18 PM View:	06-Jun-24 Grant 0	Zumwalt Leanne M Director		Akebia Therapeutics, Inc. - AKBA	69% 43.7K to 73.7K	0	0	--	--	Show Txns Hide Txns

10-Jun-24 4:19 PM View:	06-Jun-24 Grant 0	Frieson Ron Director		Akebia Therapeutics, Inc. - AKBA	69% 43.7K to 73.7K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 4:10 PM View:	31-Jan-24 Grant 0	Snow Ellen SVP, CFO and Treasurer		Akebia Therapeutics, Inc. - AKBA	40% 370.0K to 519.3K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 4:11 PM View:	31-Jan-24 Grant 0	Malabre Richard C Chief Accounting Officer		Akebia Therapeutics, Inc. - AKBA	100% 0 to 223.95K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 4:11 PM View:	31-Jan-24 Grant 0	Grund Nicholas Chief Commercial Officer		Akebia Therapeutics, Inc. - AKBA	100% 0 to 303.3K	0	0	--	--	Show Txns Hide Txns

Akebia Therapeutics, Inc. (AKBA)

Last Year

23-Nov-23 -- 22-Nov-24

Company Sentiment

Biotechnology

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--